Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,375 across all filing types
Latest filing 2020-04-29 AGM Information
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
NOTICE OF 2019 ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a detailed notice of the 2019 Annual General Meeting (AGM) of Yanzhou Coal Mining Company Limited. It includes the date, location, and agenda items for the AGM, such as approval of the board's working report, supervisory committee report, audited financial statements, profit distribution plan, director appointments, and other resolutions to be considered at the meeting. The document does not contain the actual reports or financial statements but rather announces the meeting and the matters to be voted on. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or notices about the AGM itself. The document is lengthy (15,000 characters) and detailed, consistent with an AGM notice rather than a brief announcement or proxy solicitation. Therefore, the appropriate classification is AGM Information (AGM-R).
2020-04-29 English
2019 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2019 Annual Report' and contains detailed sections typical of a full annual report, including corporate information, financial highlights, chairman's statement, management discussion and analysis, directors and senior management, corporate governance report, independent auditor's report, and consolidated financial statements. The presence of comprehensive financial data, management commentary, and auditor's report confirms this is a full annual report rather than an announcement or summary. The document length is 15,000 characters, indicating a substantive report rather than a brief notice. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2020-04-28 English
RESULTS REPORT FOR THE FIRST QUARTER OF 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RESULTS REPORT FOR THE FIRST QUARTER OF 2020' and contains detailed financial data for the first quarter of 2020, including operating income, net profit, assets, and shareholder information. It references the China Securities Regulatory Commission (CSRC) regulations on quarterly reports and includes unaudited financial statements for the quarter ending 31 March 2020. The content is comprehensive and includes substantive financial data and analysis for a period shorter than a full fiscal year, which fits the definition of an Interim / Quarterly Report. It is not merely an announcement or a certification but a full report with financial figures and commentary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2020
2020-04-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-04-28 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES ACCEPTANCE OF ITS FIRST NEW DRUG APPLICATION IN MAINLAND CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR THE FIRST-IN-CLASS PRECISION THERAPY AVAPRI
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals regarding the acceptance of its first New Drug Application (NDA) by the National Medical Products Administration (NMPA) in China for a precision therapy drug. The content focuses on regulatory acceptance of a drug application, clinical study results, and company comments on the milestone. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement of a regulatory milestone related to drug approval, not a financial report, management discussion, or investor presentation. It is not a report publication announcement since it contains substantive information about the NDA acceptance and clinical data rather than just a notice of report availability. Therefore, the document fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-04-23 English
Annual Report 2019
Annual Report Classification · 100% confidence The document is titled 'Annual Report' and contains detailed sections typical of a full annual report, including a board statement, auditor's report, financial highlights over multiple years, corporate governance, and consolidated financial statements. It references the 2019 fiscal year and includes comprehensive company information, financial data, and auditor opinions. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-04-22 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.